Switzerland’s premium OTC and Prescription Drugs market
Switzerland has a strong and premium-priced OTC and Prescription Drugs market that is among the most important ones in Europe and is worth being considered if you’re looking to expand your business.
Switzerland is not an EU member state, but it remains one of Europe’s most important OTC and pharma markets, as well as a major center for medical research for new products. In 2020, the Swiss consumer health and pharma market was valued at USD 6,3 billion and is expected to reach an ex-factory value of USD 9,4 in 2035, according to our CPC forecasts.
Given its comparatively small domestic market, Switzerland is flourishing in foreign trade. Healthcare exports account for 45% of Swiss exports, with exports worth 99.1 billion Swiss francs.
Healthcare accounts for 9.2% of the country’s gross domestic spending, which is one of the highest levels in the world. There are approximately 1,800 pharmacies registered in Switzerland and two-thirds of all medicine packs are bought in pharmacies, and in terms of value, these sales account for around 48% of total sales.
The consumer health and pharma industry is a major contributor to quality of life and prosperity in Switzerland. The country provides an attractive operating environment for innovative companies. However, it is losing ground to other countries in terms of competitiveness. For this reason, Switzerland’s 2030 OTC and pharma industry strategy is centered on three focal areas:
- Putting the focus on patients.
- Becoming a leader in research and development.
- Creating a strong economic-policy framework.
Contact the Chameleon Pharma Consulting Group to have more information about Market Entry, Regulatory topics, or GMP Certificates in Switzerland!
Switzerland OTC and pharma market in 2035
USD 9,35 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
Switzerland in numbers
Interested in this market?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.